Table 3.
Clinical features of the patients submitted to calcium-stimulation test with a final histological diagnosis of MTC.
Age, yrs | Origin | Ct, pg/ml | proCt, ng/mL | Cancer size (mm) | T | N | M | Stage | |||
---|---|---|---|---|---|---|---|---|---|---|---|
Basal | Peak | Basal | Peak | ||||||||
Females | |||||||||||
1 | 62 | #1 | 91.5 | 736 | 1.13 | 1.63 | 12 | 1 | 0 | 0 | 1 |
2 | 58 | #1 | 39.3 | 488 | 0.32 | 0.46 | 11 | 1 | 0 | 0 | 1 |
3 | 57 | #1 | 7720 | 19700 | 20.5 | 21.1 | 70 | 3 | 0 | 0 | 2 |
4 | 50 | #1 | 126 | 175 | 2.33 | 2.5 | 12 | 1 | 1a | 0 | 3 |
5 | 64 | #1 | 49.2 | 974 | 0.38 | 0.52 | 12 | 1 | 0 | 0 | 1 |
6 | 52 | #1 | 25.7 | 1010 | 0.31 | 1.59 | 6 | 1 | 0 | 0 | 1 |
7 | 52 | #1 | 83.1 | 235 | 0.64 | 0.79 | 10 | 1 | 0 | 0 | 1 |
8 | 61 | #1 | 35.3 | 366 | 0.25 | 0.61 | 11 | 1 | 0 | 0 | 1 |
9 | 27 | #1 | 68.2 | 434 | 0.24 | 0.64 | 7 | 1 | 0 | 0 | 1 |
10 | 52 | #1 | 61.6 | 538 | 0.26 | 0.37 | 8 | 1 | 0 | 0 | 1 |
11 | 64 | #2 | 89.2 | 2707 | 0.77 | 2.36 | 7 | 1 | 0 | 0 | 1 |
12 | 68 | #2 | 222 | 1251 | 1.18 | 1.63 | 11 | 1 | 0 | 0 | 1 |
13 | 66 | #3 | 11.6 | 118 | 0.04 | 0.07 | 7 | 1 | 0 | 0 | 1 |
14 | 70 | #3 | 53.7 | 678 | 0.12 | 0.4 | 4 | 1 | 0 | 0 | 1 |
Males | |||||||||||
1 | 46 | #1 | 27.7 | 1020 | 0.28 | 0.51 | 17 | 1 | 0 | 0 | 1 |
2 | 73 | #1 | 19.6 | 71.5 | 0.1 | 0.1 | 7 | 1 | 0 | 0 | 1 |
3 | 35 | #2 | 126 | 1485 | 0.51 | 0.84 | 9 | 1 | 0 | 0 | 1 |
4 | 54 | #2 | 23.8 | 665 | 0.19 | 0.29 | 16 | 1 | 0 | 0 | 1 |
5 | 66 | #2 | 47 | 1357 | 0.05 | 0.71 | 12 | 1 | 0 | 0 | 1 |
6 | 69 | #3 | 69.3 | 860 | 0.09 | 0.2 | 4 | 1 | 0 | 0 | 1 |
#1 Padua; #2 Milan; #3 Bologna; Ct, calcitonin; proCt, procalcitonin.